Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for FREE ACCESS to this landmark database

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Journal of Child Neurology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Gaggero, R.
Right arrow Articles by Faraci, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gaggero, R.
Right arrow Articles by Faraci, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Intractable Epilepsy Secondary to Cyclosporine Toxicity in Children Undergoing Allogeneic Hematopoietic Bone Marrow Transplantation

Roberto Gaggero, MD

Epilepsy Unit, Child Neurology Department, Gaslini Children's Research Institute, Genova, Italy, robertogaggero{at}ospedale-gaslini.ge.it.

Riccardo Haupt, MD

Epidemiology and Biostatistics Section, Scientific Directorate, Gaslini Children's Research Institute, Genova, Italy

Maria Paola Fondelli, MD

Neuroradiology Unit, Galliera Hospital, Genova, Italy

Raffaella De Vescovi, MD

Pediatric Neurology Department, Burlo Garofolo Institute, Trieste, Italy

Alessia Marino, MD

Epilepsy Unit, Child Neurology Department, Gaslini Children's Research Institute, Genova, Italy

Edoardo Lanino, MD

Hematology-Oncology Department, Gaslini Children's Research Institute, Genova, Italy

Sandro Dallorso, MD

Hematology-Oncology Department, Gaslini Children's Research Institute, Genova, Italy

Maura Faraci, MD

Hematology-Oncology Department, Gaslini Children's Research Institute, Genova, Italy

The long-term evolution to intractable epilepsy in children treated with cyclosporine administered for graft-versus-host-disease after hematopoietic stem cell transplantation was evaluated. In a group of 185 children treated with cyclosporine after bone marrow transplantation, 15 (8%) presented with acute seizures that were generalized in 7 and focal in 7 and had absence status in 1. Electroencephalography (EEG) and neuroimaging showed predominant abnormalities in the occipital regions. One patient died shortly after the seizure; in seven cases, seizures remitted, whereas relapses were observed in seven others. After the first year, seizures persisted chronically in four cases and evolved to intractable epilepsy. Focal temporal epilepsy was diagnosed in three cases, whereas in the fourth case, a multifocal epilepsy was observed. Magnetic resonance imaging (MRI) detected mesial temporal sclerosis in all of these cases. The risk factors associated with evolution to epilepsy included lower age at transplantation (3—5 years), more than one relapsing seizure in the first year after transplantation, and longer treatment with cyclosporine. Not only can cyclosporine cause acute central nervous system toxicity, it can also determine intractable epilepsy associated with mesial temporal sclerosis. (J Child Neurol 2006;21:861—866; DOI 10.2310/7010.2006.00196).

Journal of Child Neurology, Vol. 21, No. 10, 861-866 (2006)
DOI: 10.1177/08830738060210100501


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?